Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2012 Mar 16;21(6):980–987. doi: 10.1158/1055-9965.EPI-11-1160

Table 2.

Association of rs1202524 and 1202529 with Type I endometrial cancer, for all participants and by ethnicity

Population SNP N Frequency OR (95% CI) P

Cases Controls Cases Controls Heterzygotes Homozygotes
All women: Type I endometrial cancer cases vs controls
rs1202524 7558 16557 0.27 0.25 1.11(1.04– 1.18) 1.21(1.08– 1.35) 2.4E-05
rs1202529 7546 16541 0.27 0.25 1.11(1.04– 1.18) 1.19(1.07– 1.33) 3.2E-05
Asian women: Type I endometrial cancer cases vs controls
rs1202524 1689 3829 0.11 0.10 1.22(1.05– 1.42) 1.60(0.86– 2.96) 3.0E-03
rs1202529 1681 3812 0.11 0.10 1.22(1.05– 1.42) 1.45(0.78– 2.69) 4.6E-03
European-ancestry women: Type I endometrial cancer cases vs controls
rs1202524 6646 11797 0.32 0.31 1.07(1.00–1.15) 1.18(1.06–1.32) 1.7E-03
rs1202529 6641 11796 0.32 0.31 1.07(1.00–1.15) 1.17(1.05–1.31) 2.2E-03
HHS Vulnerability Disclosure